Evidence map›Paper›PMID 32770278›Full record

SynthesisEuropean journal of clinical pharmacology2021

Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials.

Farhad Pazan, Mirko Petrovic, Antonio Cherubini, Graziano Onder, Alfonso J Cruz-Jentoft, Michael Denkinger, Tischa J M van der Cammen, Jennifer M Stevenson, Kinda Ibrahim, Chakravarthi Rajkumar and 24 more

Erratum issuedOpen access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in European journal of clinical pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Frailty in the cardiac intensive care unit: assessment and impact.European heart journal. Acute cardiovascular care · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 15 countries.

Farhad PazanClinical Pharmacology Mannheim, Faculty of Medicine Mannheim, Ruprecht-Karls-University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Mirko PetrovicSection of Geriatrics, Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Antonio CherubiniDepartment of Geriatric Medicine, INRCA Istituto Nazionale di Ricovero e Cura per Anziani, Ancona, Italy.
Graziano OnderDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Alfonso J Cruz-JentoftServicio de Geriatría. Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
Michael DenkingerDepartment of Geriatrics, University of Ulm and Geriatric Center Ulm/Alb-Donau, Agaplesion Bethesda Hospital, Alb-Donau, Ulm, Germany.
Tischa J M van der CammenFaculty of Industrial Design Engineering, Delft University of Technology, Delft, Netherlands.
Jennifer M StevensonInstitute of Pharmaceutical Science, King's College London, London, UK.
Kinda IbrahimAcademic Geriatric Medicine, Faculty of Medicine, Southampton University, Southampton, UK.
Chakravarthi RajkumarGeriatric & Stroke Medicine, Brighton and Sussex Medical School, Brighton, UK.
Marit Stordal BakkenDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Jean-Pierre BaeyensAZ Alma, Eeklo, Belgium.
Peter CromeKeele University, Newcastle under Lyme, UK.
Thomas FrühwaldDepartment of Acute Geriatrics, Social Medical Center East, Vienna, Austria.
Paul GallagharSchool of Medicine, University College Cork, Cambridge, UK.
Adalsteinn GuðmundssonUniversity of Iceland, Geriatrics K4, Landspítali University, Reykjavík, Iceland.
Wilma KnolGeriatrics, Department of Geriatric Medicine and Expertise Centre Pharmacotherapy in Old Persons, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Denis O'MahonyDepartment of Medicine, University College Cork, Cork University Hospital, Cork, Ireland.
Alberto PilottoDepartment of Geriatric Care, Orthogeriatrics and Rehabilitation, Galliera Hospital, Genoa, Italy.
Elina RönnemaaDepartment of Public Health and Caring Sciences/Geriatrics, Uppsala, Sweden.
José Antonio Serra-RexachGeriatric Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
George SoulisOutpatient Geriatric Assessment Unit, Henry Dunant Hospital Center, Athens, Greece.
Rob J van MarumDepartment of General Medicine and Geriatric Medicine, Free University, Amsterdam, The Netherlands.
Gijsbertus ZiereSection of Geriatric Medicine, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Alpana MairEffective Prescribing and Therapeutics, Scottish Government, Edinburgh, EH1 3DG, UK.
Heinrich BurkhardtIV. Medical Department, Geriatrics, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Agnieszka Neumann-PodczaskaGeriatric Laboratory Palliative Medicine Department, Poznan University of Medical Sciences, Poznan, Poland.
Katarzyna Wieczorowska-TobisDepartment of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Marilia Andreia FernandesDepartment of Internal Medicine, Hospital Curry Cabral, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Heidi GrunerInternal Medicine Department 7.2, Hospital Curry Cabral - Centro Hospitalar Universitário Lisboa Central, EPE, Lisbon, Portugal.
Dhayana DallmeierAGAPLESION Bethesda Clinic Ulm, Ulm, Germany.
Jean-Baptiste BeuscartCHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Univ. Lille, F-59000, Lille, France.
Nathalie van der VeldeDepartment of Geriatric Medicine, Free University, Amsterdam, the Netherlands.
Martin WehlingClinical Pharmacology Mannheim, Faculty of Medicine Mannheim, Ruprecht-Karls-University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. martin.wehling@medma.uni-heidelberg.de.ORCID http://orcid.org/0000-0003-1393-1691
Heidelberg University · DEHospital Curry Cabral · PTPoznan University of Medical Sciences · PLUniversity of Amsterdam · NLBoston University · USBrighton and Sussex Medical School · GBDelft University of Technology · NLEnte Ospedaliero Ospedali Galliera · ITErasmus MC · NLGhent University Hospital · BEHenry Dunant Hospital · GRInstituto Ramón y Cajal de Investigación Sanitaria · ESIstituto Nazionale di Riposo e Cura per Anziani · ITIstituto Superiore di Sanità · ITKeele University · GBKing's College London · GBScottish Government · GBUniversidad Complutense de Madrid · ESUniversität Ulm · DEUniversité de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrailty and adverse drug effects are linked in the fact that polypharmacy is correlated with the severity of frailty; however, a causal relation has not been proven in older people with clinically manifest frailty.

methodsA literature search was performed in Medline to detect prospective randomized controlled trials (RCTs) testing the effects of pharmacological interventions or medication optimization in older frail adults on comprehensive frailty scores or partial aspects of frailty that were published from January 1998 to October 2019.

resultsTwenty-five studies were identified, 4 on comprehensive frailty scores and 21 on aspects of frailty. Two trials on comprehensive frailty scores showed positive results on frailty although the contribution of medication review in a multidimensional approach was unclear. In the studies on aspects related to frailty, ten individual drug interventions showed improvement in physical performance, muscle strength or body composition utilizing alfacalcidol, teriparatide, piroxicam, testosterone, recombinant human chorionic gonadotropin, or capromorelin. There were no studies examining negative effects of drugs on frailty.

conclusionSo far, data on a causal relationship between drugs and frailty are inconclusive or related to single-drug interventions on partial aspects of frailty. There is a clear need for RCTs on this topic that should be based on a comprehensive, internationally consistent and thus reproducible concept of frailty assessment.

Indexed as

AgedFrail ElderlyFrailtyHumansPolypharmacyRandomized Controlled Trials as TopicFrailtyInappropriate drug treatmentMedication optimizationOlder peoplePolypharmacyPrefrailty

Identifiers

PMID32770278
PMCPMC8197722
OpenAlexW3047689013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.